Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Apr 21.
Published in final edited form as: Org Lett. 2021 Oct 5;23(20):7916–7920. doi: 10.1021/acs.orglett.1c02914

Palladium-Catalyzed, Enantioselective Desymmetrization of N-Acylaziridines with Indoles

Kinney Van Hecke 1, Tyler R Benton 2, Michael Casper 3, Dustin Mauldin 4, Brandon Drake 5, Jeremy B Morgan 6
PMCID: PMC9022218  NIHMSID: NIHMS1796246  PMID: 34609884

Abstract

Ring opening reactions of meso-aziridines generate chiral amine derivatives where the control of stereochemistry is possible through enantioselective catalysis. We report the use of a diphosphine–palladium(II) catalyst for the highly enantioselective desymmetrization of N-acylaziridines with indoles. The β-tryptamine products are isolated in moderate to high yield across a range of indole and aziridine substitution patterns. The synthetic utility of β-tryptamine products is demonstrated by conversion to the brominated pyrroloindoline derivative.

Graphical Abstract

graphic file with name nihms-1796246-f0001.jpg


Carbon–nitrogen bonds are prevalent in organic small molecules of interest to the chemical community. Many nitrogen-containing compounds are chiral, resulting in the extensive development of enantioselective methods for nitrogen installation.1 Aziridines are classic synthetic intermediates that provide an opportunity to construct carbon–nitrogen bonds at chiral carbons with adjacent functional group complexity.2 Rapid development of meso-aziridine desymmetrization in recent decades was possible for a wide variety of heteroatom nucleophiles and cyanide.3 More recent catalyst systems have facilitated the introduction of complex carbon nucleophiles4 including indoles.5 Aziridine opening with indole equivalents produces substituted tryptamines that are found in a range of biologically active natural products (Figure 1).6

Figure 1.

Figure 1.

Natural products containing the tryptamine core.

Our interest in developing catalysts for aziridine desymmetrization began with the palladium-catalyzed rearrangement of N-acylaziridines to oxazolines.7 Previous success employing indoles as nucleophiles in the ring opening of N-acylaziridines8 compelled us to investigate the aziridine desymmetrization. Wang and co-workers reported the use of indoles to generate enantioenriched tryptamines under magnesium catalysis while our work was underway (Scheme 1).5a In their method, indole substitution is limited to the benzene portion (sites 4–7), except for 3-substituted indoles that produce the pyrroloindoline product.5b Herein, we report a complementary method for synthesizing tryptamines by a palladium-catalyzed aziridine desymmetrization. Our method functions under reduced catalyst loading, and substitution is tolerated at indole positions 1 and 2.

Scheme 1.

Scheme 1.

New Method for Aziridine Desymmetrization with Indoles

The investigation into the desymmetrization of isoxazole-based aziridine 5 began with catalyst conditions we previously developed for the Heine rearrangement.7 The palladium(II) catalyst derived from DTBM-SEGPHOS failed to generate tryptamine 6 in the presence of excess indole (entries 1 and 2, Table 1). A decrease in the size of the substituents on the ligand to DM-SEGPHOS led to the first indication of a product in high enantioselectivity (entries 3 and 4). Other noncoordinating counterions could be employed, but enantioselectivity decreased slightly (entries 5 and 6). A survey of alternative axially chiral diphosphine ligands did not improve the reaction outcome (entries 7–11). An alteration of the isoxazole 5-position to aziridine 7 gave an increase in yield but a slightly lower enantioselectivity (entry 12). Final optimized conditions were achieved by replacing the solvent with α,α,α-trifluorotoluene (TFT, entry 13).

Table 1.

Catalyst Optimization for the Synthesis of Enantioenriched Tryptaminesa

graphic file with name nihms-1796246-t0002.jpg
entry R ligandb X yield (%)c ee (%)d
1 Me DTBM-SEGPHOS OTf 0
2 Me DTBM-SEGPHOS bf 4 0
3 Me DM-SEGPHOS OTf 0
4 Me DM-SEGPHOS bf 4 45 91
5 Me DM-SEGPHOS SbF6 58 86
6 Me DM-SEGPHOS PF6 43 87
7 Me Tol-BINAP bf 4 32 87
8 Me DM-BINAP bf 4 42 87
9 Me DM-MeO-BIPHEP bf 4 49 89
10 Me Tol-GARPHOS bf 4 41 88
11 Me DM-GARPHOS bf 4 39 89
12 t-Bu DM-SEGPHOS bf 4 58 89
13e t-Bu DM-SEGPHOS bf 4 66 92
a

Reaction conditions: aziridine 5 or 7 (0.1 mmol), 1H-indole (0.3 mmol), and 50 mg of 4 Å powdered molecular sieves were added to the preformed catalyst (0.01 mmol of metal–ligand complex and 0.018 mmol of silver salt) in 3:2 toluene/CH2Cl2 (0.2 M) and heated to 40 °C for 48 h.

b

The DM prefix refers to 3,5-dimethylaryl substituents on phosphorus. All ligands screened were the R enantiomer with complete structures provided in the Supporting Information.

c

Isolated yield from a single run.

d

Determined by HPLC.

e

Reaction solvent was α,α,α-trifluorotoluene.

Optimized catalyst conditions were utilized to investigate the reaction substrate scope with respect to indole. The preformed [(R)-DM-SEGPHOS]Pd(BF4)2(H2O)2 catalyst (9) was determined to be the diaqua complex by X-ray crystallography with a structure similar to known diphosphine–palladium(II) diaqua complexes9 (Figure 2; see the Supporting Information). Reactions were conducted with 10 mol % 9 and excess indole to maximize the yield of tryptamine 10 (Table 2). 1H-Indole and 1-methylindole reacted at the C-3 position in moderate yield and high enantioselectivity (entries 1 and 2). A significant increase in yield occurred for related indoles when a 2-methyl substituent was added (entries 3 and 4). These results are best explained by the methyl group blocking the C-2 addition for entries 3 and 4 (when compared to entries 1 and 2).10 An ethyl group can be installed at C-2 (entry 5), but 2-phenylindole gave no product formation (data not shown). Methyl substituted indoles in positions 4–7 proceeded in varying yield but with high enantioselectivities (entries 6–9). Ether and fluoro substituents are tolerated on the indole with consistently high enantioselectivity, where the electron-deficient fluoro groups significantly reduce yield (entries 10–12). The addition of 2-methyl substituents was useful to increase both yield and enantioselectivities for several 5-substituted indoles (entries 13–15 versus entries 7, 10, and 11). The broad success of indole substitution patterns is complementary to previously reported enantioselective tryptamine synthesis by desymmetrization where 1- and 2-substituted indoles were unreactive.5a

Figure 2.

Figure 2.

[(R)-DM-SEGPHOS]Pd(H2O)2(BF4)2 crystal structure.

Table 2.

Indole Substrate Scope for Aziridine Desymmetrizationa

graphic file with name nihms-1796246-t0003.jpg
entry R1 R2 R3 yield (%)b ee (%)c
1 H H H 69 92
2 Me H H 49 95
3 H Me H 88 95
4 Me Me H 84 98
5 H Et H 78 97
6 H H 4-Me 45 88
7 H H 5-Me 66 93
8 H H 6-Me 68 94
9 H H 7-Me 59 94
10 H H 5-OMe 65 93
11 H H 5-F 32 92
12 H H 6-F 29 94
13 H Me 5-Me 86 97
14 H Me 5-OMe 88 97
15 H Me 5-F 59 97
a

Reaction conditions: aziridine 7 (0.2 mmol), indole (0.8 mmol), catalyst 9 (0.02 mmol), and 100 mg of 4 Å powdered molecular sieves in α,α,α-trifluorotoluene (1 mL) were heated to 40 °C for 48 h.

b

Isolated yield from two or more runs.

c

Determined by HPLC.

The aziridine backbone was modified to investigate the reaction scope with 2-methylindole (11, Table 3). Substituents containing functionalized 6-membered ring backbones (entries 1 and 2) also gave excellent results when compared to aziridine 7 (entry 3, Table 2). Ring size played a role in the reaction outcome with the smaller ring substrate (entry 3) slightly decreasing ee and the larger ring substrate (entry 4) decreasing yield. Two aziridines with acyclic substituents led to product in good yield and excellent ee as a single diastereomer (entries 5 and 6). The addition of ether substituents was possible but drastically reduced the reaction rate. A dioxepin substrate gave synthetically useful results over an extend reaction period (entry 7), while introduction of a tetrahydrofuran ring decrease yield and % ee (entry 8). The ether substituent may bind to palladium, but the reason for poor selectivity in entry 8 is unclear. We observed similar results with a related catalyst for aziridine rearrangement.7

Table 3.

Aziridine Substrate Scope for Tryptamine Synthesisa

graphic file with name nihms-1796246-t0004.jpg
entry aziridine time (h) yield (%)b ee (%)c
1 graphic file with name nihms-1796246-t0005.jpg 48 88 97
2 graphic file with name nihms-1796246-t0006.jpg 72 81 98
3 graphic file with name nihms-1796246-t0007.jpg 48 79 94
4 graphic file with name nihms-1796246-t0008.jpg 72 62 97
5 graphic file with name nihms-1796246-t0009.jpg 48 73 95
6 graphic file with name nihms-1796246-t0010.jpg 48 64 93
7 graphic file with name nihms-1796246-t0011.jpg 120 53 91
8 graphic file with name nihms-1796246-t0012.jpg 168 25 53
a

Reaction conditions: aziridine (0.2 mmol), 2-methylindole (0.8 mmol), catalyst 9 (0.02 mmol), and 100 mg of 4 Å powdered molecular sieves in α,α,α-trifluorotoluene (1 mL) were heated to 40 °C for the time indicated.

b

Isolated yield from two or more runs.

c

Determined by HPLC.

Reaction conditions were modified for a gram scale experiment. We hoped to minimize the indole necessary while also reducing catalyst loading. The new reaction conditions include 5 mol % catalyst, standard organic solvents, and only two equivalents of indole. Despite the adjustments, tryptamine 13 could still be produced in good yield with high enantioselectivity (Scheme 2). The absolute configuration of 13 was determined by X-ray crystallography (see the Supporting Information).

Scheme 2.

Scheme 2.

Gram-Scale Reaction Conditions

The isoxazole amide directing group required for optimized catalyst conditions can be readily removed. Treatment of tryptamine 8 with excess Boc2O leads to Boc protection at both N–H bonds (Scheme 3). The intermediate can be directly treated with a basic methanol solution to remove the acylisoxazole group in excellent yield over 2 steps. Boc-protected tryptamine 14 undergoes diastereoselective bromination to provide a 76% yield of pyrroloindoline 15,11 which could be useful for further complex molecular synthesis.

Scheme 3. Tryptamine Deprotection and Functionalization.

Scheme 3.

aReaction conditions: 1) Boc2O, DMAP, THF, 60 °C, 6 h: 2) K2CO3, MeOH, 23 °C, 1 h, 88% over 2 steps. bNBS, PPTS CH2Cl2, −10 °C, 6 h, 76%, 5:1 dr.

The proposed catalytic cycle is depicted in Figure 3. Our previous work on related palladium catalysts in aziridine desymmetrization indirectly indicated isoxazole binding.7 The formation of complex 16 initially occurs with the displacement of water from precatalyst 9.12 We have indicated bidentate coordination to the carbonyl oxygen but recognize N-acylaziridines are twisted amides that may bind via nitrogen. Enantioselective attack by 11 occurs to generate 17. After rearomatization with proton transfer, complex 18 will undergo ligand exchange with 3 to release the product (12) and turn over the catalyst. We view the role of molecular sieves as maintaining a dry solution to prevent catalyst decomposition during heating that may lead to a background reaction.

Figure 3.

Figure 3.

Proposed catalytic cycle.

We have detailed a new palladium-catalyzed method for the desymmetrization of meso-aziridines in high enantioselectivity. The conditions are complementary to current literature, providing rapid access to tryptamines with various substitution patterns at low catalyst loading. The necessary isoxazole protecting group can be readily removed to generate a synthetically useful intermediate. Initial NMR experiments suggest a catalyst–aziridine complex along the catalytic cycle.

Supplementary Material

SI-1
SI-2

ACKNOWLEDGMENTS

The authors are grateful to the National Institute of General Medical Sciences of the National Institutes of Health (R15GM114766) for financial support. The HRMS data was collected from a Bruker MicrOTOF-Q II instrument purchased with funds from the National Science Foundation (CHE-1039784) and the University of North Carolina Wilmington. The 600 MHz NMR data was obtained using a Bruker instrument purchased with funds from the National Science Foundation (CHE-0821552). The authors thank Dr. John Bacsa (Emory University) and the Emory X-ray Crystallography Facility for the X-ray structural analysis.

Footnotes

Supporting Information

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.orglett.1c02914.

Detailed experimental procedures and analytical data;

NMR data for all new compounds (PDF)

Crystallographic data (PDF)

Accession Codes

CCDC 1816152 and 1816155 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.

Complete contact information is available at: https://pubs.acs.org/10.1021/acs.orglett.1c02914

The authors declare no competing financial interest.

Contributor Information

Kinney Van Hecke, Department of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.

Tyler R. Benton, Department of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States

Michael Casper, Department of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.

Dustin Mauldin, Department of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.

Brandon Drake, Department of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.

Jeremy B. Morgan, Department of Chemistry and Biochemistry, University of North Carolina Wilmington, Wilmington, North Carolina 28403, United States.

REFERENCES

  • (1).(a) Royer J; Husson HP Asymmetric Synthesis of Nitrogen Heterocycles; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2009. [Google Scholar]; (b) Nugent TC Chiral Amine Synthesis; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2010. [Google Scholar]; (c) Mailyan AK; Eickhoff JA; Minakova AS; Gu ZH; Lu P; Zakarian A Cutting-Edge and Time-Honored Strategies for Stereoselective Construction of C–N Bonds in Total Synthesis. Chem. Rev 2016, 116, 4441–4557. [DOI] [PubMed] [Google Scholar]
  • (2).(a) Dahanukar VH; Zavialov IA Aziridines and Aziridinium Ions in the Practical Synthesis of Pharmaceutical Intermediates - A Perspective. Curr. Opin. Drug Dis. Dev 2002, 5, 918–927. [PubMed] [Google Scholar]; (b) Hu XE Nucleophilic Ring Opening of Aziridines. Tetrahedron 2004, 60, 2701–2743. [Google Scholar]; (c) Krake SH; Bergmeier SC Inter- and Intramolecular Reactions of Epoxides and Aziridines with p-Nucleophiles. Tetrahedron 2010, 66, 7337–7360. [Google Scholar]; (d) Ghorai MK; Bhattacharyya A; Das S; Chauhan N Ring Expansions of Activated Aziridines and Azetidines. Top. Heterocycl. Chem 2015, 41, 49–142. [Google Scholar]; (e) Singh G Advances in Synthesis and Chemistry of Aziridines. In Advances in Heterocyclic Chemistry; Scriven EFV, Ramsden CA, Eds.; Elsevier, Inc., 2019; Vol. 129, pp 245–335. [Google Scholar]
  • (3).(a) Schneider C Catalytic, Enantioselective Ring Opening of Aziridines. Angew. Chem., Int. Ed 2009, 48, 2082–2084. [DOI] [PubMed] [Google Scholar]; (b) Wang P-A Organocatalyzed Enantioselective Desymmetrization of Aziridines and Epoxides. Beilstein J. Org. Chem 2013, 9, 1677–1695. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Wang Z; Hong WX; Sun J Organocatalytic Enantioselective Desymmetrization of meso-Aziridines and Prochiral Azetidines. Curr. Org. Chem 2016, 20, 1851–1861. [Google Scholar]; (d) Akhtar R; Naqvi SAR; Zahoor AF; Saleem S Nucleophilic Ring Opening Reactions of Aziridines. Mol. Diversity 2018, 22, 447–501. [DOI] [PubMed] [Google Scholar]
  • (4).(a) Müller P; Nury P Copper-Catalyzed Desymmetrization of N-Sulfonylaziridines with Methylmagnesium Halides. Org. Lett 1999, 1, 439–441. [Google Scholar]; (b) Müller P; Nury P Desymmetrization of meso-NSulfonylaziridines with Chiral Nonracemic Nucleophiles and Bases. Helv. Chim. Acta 2001, 84, 662–677. [Google Scholar]; (c) Xu YJ; Lin LQ; Kanai M; Matsunaga S; Shibasaki M Catalytic Asymmetric Ring-Opening of meso-Aziridines with Malonates under Heterodinuclear Rare Earth Metal Schiff Base Catalysis. J. Am. Chem. Soc 2011, 133, 5791–5793. [DOI] [PubMed] [Google Scholar]; (d) Li D; Wang L; Yang D; Zhang B; Wang R Catalytic Desymmetrization of meso-Aziridines with Benzofuran2(3H)-Ones Employing a Simple In Situ-Generated Magnesium Catalyst. ACS Catal. 2015, 5, 7432–7436. [Google Scholar]; (e) Wang L; Yang D; Li D; Wang R Catalytic Enantioselective Ring-Opening and Ring-Closing Reactions of 3-Isothiocyanato Oxindoles and N-(2-Picolinoyl)aziridines. Org. Lett 2015, 17, 3004–3007. [DOI] [PubMed] [Google Scholar]; (f) Yang D; Wang L; Han F; Li D; Zhao D; Wang R Intermolecular Enantioselective Dearomatization Reaction of β-Naphthol Using meso-Aziridine: A Bifunctional In Situ Generated Magnesium Catalyst. Angew. Chem., Int. Ed 2015, 54, 2185–2189. [DOI] [PubMed] [Google Scholar]; (g) Li D; Wang Y; Wang L; Wang J; Wang P; Wang K; Lin L; Liu D; Jiang X; Yang D Simple Magnesium Catalyst Mediated γ-Butyrolactams in Desymmetrization of meso-Aziridines. Chem. Commun 2016, 52, 9640–9643. [DOI] [PubMed] [Google Scholar]; (h) Wang L; Li D; Yang D; Wang K; Wang J; Wang P; Su W; Wang R Catalytic Asymmetric Ring-Opening Reactions of Aziridines with 3-Aryl-Oxindoles. Chem. - Asian J 2016, 11, 691–695. [DOI] [PubMed] [Google Scholar]; (i) Shiomi N; Kuroda M; Nakamura S Desymmetrization of Aziridine with Malononitrile using Cinchona Alkaloid Amide/Zinc(II) Catalysts. Chem. Commun 2017, 53, 1817–1820. [DOI] [PubMed] [Google Scholar]; (j) Wang L; Yang D; Li D; Zhu H; Wang P; Liu X; Bai L; Wang R Diversiform Reactivity of Naphthols in Asymmetric Dearomatization or O-Alkylation Reactions with Aziridines. Adv. Synth. Catal 2018, 360, 4491–4496. [Google Scholar]; (k) Li D; Wang L; Zhu H; Bai L; Yang Y; Zhang M; Yang D; Wang R Catalytic Asymmetric Reactions of α-Isocyanoacetates and meso-Aziridines Mediated by an in-Situ-Generated Magnesium Catalytic Method. Org. Lett 2019, 21, 4717–4720. [DOI] [PubMed] [Google Scholar]; (l) Li X; Xiong Q; Guan M; Dong S; Liu X; Feng X Divergent Synthesis of Enantioenriched β-Functional Amines via Desymmetrization of meso-Aziridines with Isocyanides. Org. Lett 2019, 21, 6096–6101. [DOI] [PubMed] [Google Scholar]
  • (5).(a) Yang D; Wang L; Han F; Li D; Zhao D; Cao Y; Ma Y; Kong W; Sun Q; Wang R Highly Enantioselective Ring-Opening Reactions of Aziridines with Indole and Its Application in the Building of C-3-Halogenated Pyrroloindolines. Chem. - Eur. J 2014, 20, 16478–16483. [DOI] [PubMed] [Google Scholar]; (b) Wang L; Yang D; Han F; Li D; Zhao D; Wang R Catalytic Asymmetric Construction of Pyrroloindolines via an in Situ Generated Magnesium Catalyst. Org. Lett 2015, 17, 176–179. [DOI] [PubMed] [Google Scholar]
  • (6).(a) Holzapfel CW The Isolation and Structure of Cyclopiazonic Acid, a Toxic Metabolite of Penicillium Cyclopium Westling. Tetrahedron 1968, 24, 2101–2119. [DOI] [PubMed] [Google Scholar]; (b) Richter JM; Ishihara Y; Masuda T; Whitefield BW; Llamas T; Pohjakallio A; Baran PS Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and Welwitindolinones via a Redox Economic Approach. J. Am. Chem. Soc 2008, 130, 17938–17954. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Kochanowska-Karamyan AJ; Hamann MT Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety. Chem. Rev 2010, 110, 4489–4497. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Ruiz-Sanchis P; Savina SA; Albericio F; Alvarez M Structure, Bioactivity and Synthesis of Natural Products with Hexahydropyrrolo[2,3-b]indole. Chem. - Eur. J 2011, 17, 1388–1408. [DOI] [PubMed] [Google Scholar]; (e) Walton K; Berry JP Indole Alkaloids of the Stigonematales (Cyanophyta): Chemical Diversity, Biosynthesis and Biological Activity. Mar. Drugs 2016, 14, 73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Punk M; Merkley C; Kennedy K; Morgan JB Palladium-Catalyzed, Enantioselective Heine Reaction. ACS Catal. 2016, 6, 4694–4698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Rubin HN; Van Hecke K; Mills JJ; Cockrell J; Morgan JB Enantiospecific Synthesis of β-Substituted Tryptamines. Org. Lett 2017, 19, 4976–4979. [DOI] [PubMed] [Google Scholar]
  • (9).(a) Sodeoka M; Tokunoh R; Miyazaki F; Hagiwara E; Shibasaki M Stable Diaqua Palladium(II) Complexes of BINAP and Tol-BINAP as Highly Efficient Catalysts for Asymmetric Aldol Reactions. Synlett 1997, 1997, 463–466. [Google Scholar]; (b) Dubs C; Hamashima Y; Sasamoto N; Seidel TM; Suzuki S; Hashizume D; Sodeoka M Mechanistic Studies on the Catalytic Asymmetric Mannich-Type Reaction with Dihydroisoquinolines and Development of Oxidative Mannich-Type Reactions Starting from Tetrahydroisoquinolines. J. Org. Chem 2008, 73, 5859–5871. [DOI] [PubMed] [Google Scholar]; For a crystal structure of a known DM-SEGPHOS–palladium(II) complex, see:; Phua PH; White AJP; de Vries JG; Hii KK Enabling Ligand Screening for Palladium-Catalysed Enantioselective Aza-Michael Addition Reactions. Adv. Synth. Catal 2006, 348, 587–592. [Google Scholar]
  • (10).The isomeric C-2 indole addition product for entry 1 has been observed. Also, 3-methylindole gives a low yield of the C-2 indole addition product.
  • (11).(a) Espejo VR; Rainier JD An Expeditious Synthesis of C(3)–N(1’) Heterodimeric Indolines. J. Am. Chem. Soc 2008, 130, 12894–12895. [DOI] [PubMed] [Google Scholar]; (b) López CS; Pérez-Balado C; Rodríguez-Graña P; de Lera ÁR Mechanistic Insights into the Stereocontrolled Synthesis of Hexahydropyrrolo[2,3-b]indoles by Electrophilic Activation of Tryptophan Derivatives. Org. Lett 2008, 10, 77–80. [DOI] [PubMed] [Google Scholar]
  • (12). 1H and 31P NMR data for the mixtures of catalyst (9) and substrates (7 and 11) that support complex 16 are provided in the Supporting Information.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI-1
SI-2

RESOURCES